BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Iizuka M, Etou T, Sagara S. Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy. World J Gastroenterol 2022; 28(34): 4959-4972 [PMID: 36160647 DOI: 10.3748/wjg.v28.i34.4959]
URL: https://www.wjgnet.com/1007-9327/full/v28/i34/4959.htm
Number Citing Articles
Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng. IBD barriers across the continents – East AsiaTherapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231212089
Filippo Vernia, Angelo Viscido, Giovanni Latella. Adsorptive cytapheresis in ulcerative colitis: A non‐pharmacological therapeutic approach revisitedJournal of Clinical Apheresis 2023;  doi: 10.1002/jca.22091
Esteban Sáez‐González, Inés Moret‐Tatay, Guillermo Bastida, Mariam Aguas, Marisa Iborra, Pilar Nos, Belén Beltrán. MicroRNA and granulocyte‐monocyte adsorption apheresis combotherapy after inadequate response to anti‐TNF agents in ulcerative colitisJournal of Clinical Apheresis 2023;  doi: 10.1002/jca.22101
Iago Rodríguez-Lago, Leticia Abecia, Iratxe Seoane, Juan Anguita, José Luis Cabriada. An in vitro analysis of the interaction between infliximab and granulocyte–monocyte apheresisGastroenterología y Hepatología 2023;  doi: 10.1016/j.gastrohep.2023.07.001